Showing results (1-10 of 446) with videos related to

Sort By:
Pageof 45
Nature Reviews. Urology|June 6, 2009
Clinical trials: 'clinical integration': laudable, but challengingE David Crawford, Catherine M Tangen
The Journal of Urology|December 13, 2002
Metastatic carcinoma of the prostate: identifying prognostic groups using recursive partitioningTracy R Glass, Catherine M Tangen, E David Crawford, et al.
Urologic Oncology|March 28, 2008
Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancerSeth P Lerner, Catherine M Tangen, Heidi Sucharew, et al.
The Journal of Urology|April 18, 2007
Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancerSeth P Lerner, Catherine M Tangen, Heidi Sucharew, et al.
The Journal of Urology|November 13, 2004
Prognostic value of anemia in newly diagnosed metastatic prostate cancer: a multivariate analysis of southwest oncology group study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
Cancer Research|September 18, 2002
The possible role of postoperative azotemia in enhanced survival of patients with metastatic renal cancer after cytoreductive nephrectomyRobert A Gatenby, Edward T Gawlinski, Catherine M Tangen, et al.
The Journal of Urology|December 23, 2008
Predictors of survival of advanced renal cell carcinoma: long-term results from Southwest Oncology Group Trial S8949Primo N Lara, Catherine M Tangen, Sarah J Conlon, et al.
Clinical Prostate Cancer|March 30, 2004
Ten-year survival in patients with metastatic prostate cancerCatherine M Tangen, James R Faulkner, E David Crawford, et al.
Cancer|June 29, 2006
The prognostic value of hemoglobin change after initiating androgen-deprivation therapy for newly diagnosed metastatic prostate cancer: A multivariate analysis of Southwest Oncology Group Study 8894Tomasz M Beer, Catherine M Tangen, Lisa B Bland, et al.
The Journal of Urology|September 18, 2007
Association of body mass index with response and survival in men with metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916R Bruce Montgomery, Bryan Goldman, Catherine M Tangen, et al.
Pageof 45